The manufacturer's
Press Release.
Previous studies have found that TELINTRA can raise blood counts of MDS patients, even for intermediate and high-risk MDS.
For more information about TELINTRA, see
Telik.com.
Phase II studies test for safety and efficacy, with a larger group of patients than Phase I studies, and can also test dosage levels. For further information about trial phases, see any of the following:
CenterWatch Glossary
What is a Clinical Trial?
Phase 1, 2, 3 and 4 Trials